On June 23, 2025, the United States District Court for the District of Delaware appointed Entwistle & Cappucci LLP as Lead Counsel in the securities action against Cerevel Therapeutics Holdings, Inc. (“Cerevel” or the “Company”) and related defendants. The case is brought on behalf of all persons or entities that: (a) sold…

Entwistle & Cappucci LLP today announced that it filed a First Amended Class Action Complaint (“Complaint”) against KnowBe4, Inc. (“KnowBe4”), certain of KnowBe4’s directors, KKR & Co. Inc., Elephant Partners, Vista Equity Partners Management, LLC (“Vista”) and certain of their affiliates (collectively, “Defendants”) on behalf of a class (“Class”) consisting of all…

Entwistle & Cappucci LLP today announced that its ongoing investigation has led to the filing of a class action (“Action”) against KnowBe4, Inc. (“KnowBe4”), certain of KnowBe4’s directors, KKR & Co. Inc., Elephant Partners, Vista Equity Partners Management, LLC (“Vista”) and certain of their affiliates (collectively, “Defendants”) on behalf of a class…

Entwistle & Cappucci LLP (“Entwistle & Cappucci”) today announced that its ongoing investigation has led to the filing of a class action (the “Action”) against Cerevel Therapeutics Holdings, Inc. (“Cerevel” or the “Company”), Bain Capital Investors, LLC (“Bain”) and Pfizer, Inc. (“Pfizer”) on behalf of a class (the “Class”) consisting of all…

Entwistle & Cappucci LLP (“Entwistle & Cappucci”) is investigating potential federal securities law violations on behalf of its clients and other former holders of Cerevel Therapeutics Holdings, Inc. (“Cerevel” or the “Company”) (NASDAQ: CERE) common stock. Cerevel was a publicly traded biopharmaceutical company that was acquired by AbbVie, Inc. in August 2024….

On March 20, 2025, the United States District Court for the Middle District of Tennessee appointed Entwistle & Cappucci LLP as Co-Lead Counsel in the securities class action against Revance Therapeutics, Inc. (“Revance” or the “Company”) and related defendants (collectively, “Defendants”). In August 2024, Revance and skincare product company Crown Laboratories, Inc….

On March 7, 2025, the United States District Court for the District of Delaware appointed Entwistle & Cappucci LLP as Lead Counsel in the securities class action against Capri Holdings Limited (“Capri”), Tapestry, Inc. (“Tapestry”) and related defendants (collectively, “Defendants”). The case is brought on behalf of a class consisting of all persons who…

On February 12, 2025, the United States District Court for the District of Delaware appointed Entwistle & Cappucci LLP as Co-Lead Counsel in the securities fraud class action against EngageSmart, Inc. (“EngageSmart”) and related defendants (collectively, “Defendants”). The action alleges that Defendants made materially false and misleading statements and omissions of material…

Entwistle & Cappucci LLP recently entered into a $126.3 million cash settlement on behalf of a Class of investors led by its institutional and individual clients.  The settlement was achieved after three weeks of jury trial and nearly six years of litigation arising from the catastrophic collapse and multi-billion-dollar asset write down…